https://www.statnews.com/2025/08/15/wegovy-mash-novo-nordisk/
0
0
8/15/25 at 10:10pm
Organization
STAT
Author
Elaine Chen
32 words
0
Comments
Novo Nordisk’s obesity drug Wegovy was cleared by U.S. regulators to treat an increasingly common liver disease, MASH.
You are the first to view
Create an account
or login to join the discussion